Brief: Aethlon Medical Announces U.S. FDA Approval Of Hemopurifier Covid-19 Study Protocol Amendment
11/07/2022 13:11
July 11 (Reuters) - Aethlon Medical Inc AEMD.O :
* AETHLON MEDICAL ANNOUNCES U.S. FDA APPROVAL OF
HEMOPURIFIER
COVID-19 STUDY PROTOCOL AMENDMENT
Source text for Eikon: ID:nPn1kspKma
Further company coverage: AEMD.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Aethlon Medical
See all newsU.S. STOCKS ON THE MOVE -Nebius, Securitize, Viant Technology
U.S. STOCKS ON THE MOVE -GlobalFoundries, Lucid, Phillips 66
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Applied Digital
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical skyrockets after merger with North Immunology